日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
29/08/2025 | UBS Group AG | 1306(L) | 34,433,806(L) | 457,471,387(L) 480,498,558(S) | 11.76 12.36 | |
28/08/2025 | UBS Group AG | 1306(L) | 30,493,214(L) | 458,526,444(L) 481,751,115(S) | 11.79 12.39 | |
25/08/2025 | UBS Group AG | 1306(L) | 19,712,080(L) | 455,167,154(L) 483,072,509(S) | 11.70 12.42 | |
22/08/2025 | Ong Tiong Sin | 1201(L) | -6,599,500(L) | HKD3.766(L) | 271,823,083(L) | 6.99 |
22/08/2025 | RRJ Capital Master Fund IV, L.P. | 1201(L) | -6,599,500(L) | HKD3.766(L) | 271,823,083(L) | 6.99 |
22/08/2025 | RRJ Capital IV Ltd | 1201(L) | -6,599,500(L) | HKD3.766(L) | 271,823,083(L) | 6.99 |
22/08/2025 | Kale Asset Holding Ltd | 1201(L) | -6,599,500(L) | HKD3.766(L) | 271,823,083(L) | 6.99 |
21/08/2025 | UBS Group AG | 1305(L) | 19,712,110(L) | 450,756,512(L) 479,169,770(S) | 11.59 12.32 | |
20/08/2025 | Shorea LBG | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.04 5.46 | ||
20/08/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.04 5.46 | ||
20/08/2025 | 刘殿波 | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.04 5.46 | ||
20/08/2025 | LuYe Pharmaceutical International Co., Ltd. | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.04 5.46 | ||
20/08/2025 | Nelumbo Investments Limited | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.04 5.46 | ||
20/08/2025 | Ginkgo (PTC) Limited | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.04 5.46 | ||
20/08/2025 | Luye Life Sciences Group Ltd | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.04 5.46 | ||
20/08/2025 | Luye Pharma Holdings Ltd. | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.04 5.46 | ||
19/08/2025 | RRJ Capital Master Fund IV, L.P. | 1303(L) | 52,919,389(L) | 296,348,583(L) | 7.73 | |
19/08/2025 | RRJ Capital IV Ltd | 1303(L) | 52,919,389(L) | 296,348,583(L) | 7.73 | |
19/08/2025 | Kale Asset Holding Ltd | 1303(L) | 52,919,389(L) | 296,348,583(L) | 7.73 | |
19/08/2025 | Ong Tiong Sin | 1303(L) | 52,919,389(L) | 296,348,583(L) | 7.73 | |
14/08/2025 | 刘殿波 | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.49 5.53 | ||
14/08/2025 | Ginkgo (PTC) Limited | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.49 5.53 | ||
14/08/2025 | Luye Life Sciences Group Ltd | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.49 5.53 | ||
14/08/2025 | LuYe Pharmaceutical International Co., Ltd. | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.49 5.53 | ||
14/08/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.49 5.53 | ||
14/08/2025 | Shorea LBG | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.49 5.53 | ||
14/08/2025 | Luye Pharma Holdings Ltd. | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.49 5.53 | ||
14/08/2025 | Nelumbo Investments Limited | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.49 5.53 | ||
13/08/2025 | RRJ Capital Master Fund IV, L.P. | 1201(L) | -11,246,000(L) | HKD3.763(L) | 300,070,338(L) | 7.93 |
13/08/2025 | Ong Tiong Sin | 1201(L) | -11,246,000(L) | HKD3.763(L) | 300,070,338(L) | 7.93 |
13/08/2025 | Kale Asset Holding Ltd | 1201(L) | -11,246,000(L) | HKD3.763(L) | 300,070,338(L) | 7.93 |
13/08/2025 | UBS Group AG | 1113(L) | -3,427,958(L) | 451,048,225(L) 479,839,058(S) | 11.92 12.68 | |
13/08/2025 | RRJ Capital IV Ltd | 1201(L) | -11,246,000(L) | HKD3.763(L) | 300,070,338(L) | 7.93 |
12/08/2025 | UBS Group AG | 1306(L) | 20,335,386(L) | 454,535,503(L) 483,541,016(S) | 12.02 12.78 | |
11/08/2025 | UBS Group AG | 1113(L) | +591,500(L) | 454,221,597(L) 483,530,610(S) | 12.01 12.78 | |
01/08/2025 | Nelumbo Investments Limited | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.94 5.61 | ||
01/08/2025 | 刘殿波 | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.94 5.61 | ||
01/08/2025 | Luye Life Sciences Group Ltd | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.94 5.61 | ||
01/08/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.94 5.61 | ||
01/08/2025 | LuYe Pharmaceutical International Co., Ltd. | 1213(L) 1213(S) | 1,246,108,703(L) 212,229,950(S) | 32.94 5.61 | ||
1 2 3 4 5 6 7 8 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 05/09/2025 15:06 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |